Ph.D. from the University of Amsterdam. Co-founder of Gero, a data-driven biotech company. An author of 75+ published papers in multiple domain areas.
Speaking In
[On Demand]

Gero is the next-gen AI drug discovery company utilizing real-world big clinical, genetic (WES),…